The serum IL‐23 level predicts the response to pegylated interferon therapy in patients with chronic hepatitis B

Publisher： John Wiley & Sons Inc

E-ISSN： 1478-3231|35|5|1549-1556

ISSN： 1478-3223

Source： LIVER INTERNATIONAL (ELECTRONIC), Vol.35, Iss.5, 2015-05, pp. : 1549-1556

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mutations in non-structural 5A and rapid viral response to pegylated interferon-α-2b plus ribavirin therapy are associated with therapeutic efficacy in patients with genotype 1b chronic hepatitis C

By                                                  

International Journal of Molecular Medicine, Vol. 30, Iss. 5, 2012-01 ,pp. : 1048-1052

Spandidos Publications

Access to resources Recommend Favorite

HLA‐DP, IL28B gene polymorphisms and IFN

By  

HEPATOLOGY RESEARCH, Vol. 44, Iss. 9, 2014-09 ,pp. : 1000-1007

John Wiley & Sons Inc

Access to resources Recommend Favorite

Interferon Therapy of Chronic Hepatitis B

By  

Intervirology, Vol. 57, Iss. 3-4, 2014-07 ,pp. : 163-170

Karger

Access to resources Recommend Favorite

The royal wedding in chronic hepatitis B: The haves and the have‐nots for the combination of pegylated interferon and nucleos(t)ide therapy

By  

HEPATOLOGY, Vol. 61, Iss. 5, 2015-05 ,pp. : 1459-1461

John Wiley & Sons Inc

Access to resources Recommend Favorite

Incidence of Depression in Patients with Chronic Hepatitis C Receiving Combination Therapy of Pegylated Interferon-Alpha and Ribavirin

By  

Psychotherapy and Psychosomatics, Vol. 83, Iss. 5, 2014-08 ,pp. : 308-309

Karger

Access to resources Recommend Favorite